VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by mtvrdonon Mar 08, 2017 4:22pm

127 Views

Post# 25953382

RE:RE:Chines Govt is majority shareholder

There is no SEDI filing to this effect.

I think there might be some confusion here. They do have a Chinese manufacturing partner company that is also helping market the technology in China and go through CFDA approvals (Chinese equivalent of FDA).

Chinese gov't itself has no stake in VPT. The technology is expected to be a good fit in the large Chinese market as the Chinese already have fairly advanced cardiac ultrasound technology which VPT's products work well with.

Bullboard Posts

Consumer advocacy law firm investigates Microsoft over X-Box data concerns